Hiroyuki Funaoka

Summary

Affiliation: Dainippon Sumitomo Pharma Co
Country: Japan

Publications

  1. ncbi Development of a high-specificity enzyme-linked immunosorbent assay (ELISA) system for the quantification and validation of intact rat osteocalcin
    Hiroyuki Funaoka
    Department of Public Health, Health Management and Policy, Nara Medical University School of Medicine, 840 Shijo Cho, Kashihara, Nara, 634 8521, Japan
    Immunol Invest 39:54-73. 2010
  2. ncbi [Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases]
    Hiroyuki Funaoka
    DS Pharma Biomedical Co, Ltd, Suita 564 0053, Japan
    Rinsho Byori 58:162-8. 2010
  3. ncbi Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells
    Akifumi Nakamura
    Department of Orthopedic Surgery, Health Management, and Policy, School of Medicine, Nara Medical University, Kashihara, Nara, Japan
    Tissue Eng Part C Methods 15:169-80. 2009
  4. ncbi Development of a high-specificity sandwich ELISA system for the quantification of human intestinal fatty acid-binding protein (I-FABP) concentrations
    Hiroyuki Funaoka
    DS Pharma Biomedical Co, Ltd, Osaka, Japan
    Immunol Invest 40:223-42. 2011
  5. ncbi Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP
    Satoshi Kajiura
    Dainippon Sumitomo Pharma Co, Ltd, Osaka, Japan
    J Immunoassay Immunochem 29:19-41. 2008
  6. ncbi Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of guinea-pig immunoglobulin e
    Makoto Nishimura
    Dainippon Sumitomo Pharma Co, Ltd, Suita, Osaka, Japan
    J Pharmacol Sci 101:58-65. 2006

Collaborators

Detail Information

Publications6

  1. ncbi Development of a high-specificity enzyme-linked immunosorbent assay (ELISA) system for the quantification and validation of intact rat osteocalcin
    Hiroyuki Funaoka
    Department of Public Health, Health Management and Policy, Nara Medical University School of Medicine, 840 Shijo Cho, Kashihara, Nara, 634 8521, Japan
    Immunol Invest 39:54-73. 2010
    ..It was established that this ELISA system would be suitable for quantitative assessment of bone formation by cultured cells with or without scaffolds in rat experimental models...
  2. ncbi [Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases]
    Hiroyuki Funaoka
    DS Pharma Biomedical Co, Ltd, Suita 564 0053, Japan
    Rinsho Byori 58:162-8. 2010
    ..In considering the clinical potential of serum I-FABP concentration, this sandwich ELISA system may contribute as a tool to perform differential diagnosis of acute abdomen with mucosal damage of the small intestine...
  3. ncbi Osteocalcin secretion as an early marker of in vitro osteogenic differentiation of rat mesenchymal stem cells
    Akifumi Nakamura
    Department of Orthopedic Surgery, Health Management, and Policy, School of Medicine, Nara Medical University, Kashihara, Nara, Japan
    Tissue Eng Part C Methods 15:169-80. 2009
    ....
  4. ncbi Development of a high-specificity sandwich ELISA system for the quantification of human intestinal fatty acid-binding protein (I-FABP) concentrations
    Hiroyuki Funaoka
    DS Pharma Biomedical Co, Ltd, Osaka, Japan
    Immunol Invest 40:223-42. 2011
    ..Thus, this ELISA system could be used to accurately quantify human I-FABP concentrations in serum samples. These results suggest that it could be used as a new biomarker for the diagnosis of small bowel disease...
  5. ncbi Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP
    Satoshi Kajiura
    Dainippon Sumitomo Pharma Co, Ltd, Osaka, Japan
    J Immunoassay Immunochem 29:19-41. 2008
    ..It is anticipated that, in the near future, such a method for measuring I-FABP will be developed as a useful tool for diagnosing intestinal ischemia by using some of these antibodies...
  6. ncbi Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of guinea-pig immunoglobulin e
    Makoto Nishimura
    Dainippon Sumitomo Pharma Co, Ltd, Suita, Osaka, Japan
    J Pharmacol Sci 101:58-65. 2006
    ..6 ng/mL in normal guinea pigs. The present ELISA is useful and practical for specific measurement of the guinea-pig IgE, and it is surmised that it would be suitable for use in allergological and pharmacological research...